CDX0239-PBD

N/A

Report date: 2025/09/22 11:55:34

Base Information

Drug NameCDX0239-PBD
Drug Alias NameCDX0239-PBD
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnaplastic lymphoma kinase modulators
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsColorectal NeoplasmsNeuroblastomaRhabdomyosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsNeuroblastomaRhabdomyosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A